 The process of drug discovery
At an estimated budget of $7.9 billion in 2004 for research & development (R&D), Pfizer Inc. boasts of the industry's largest pharmaceutical R&D organization: Pfizer Global Research and Development.
Pfizer's search for new treatments spans hundreds of research projects across 18 therapeutic areas. This is much more than any other company. Our scientists, clinicians, technicians, and other professionals employ state-of-the-art tools ranging from robotic high-throughput screening (a method pioneered by Pfizer) to sophisticated genomic studies, and deliver a steady stream of innovative new products that enhance human and animal health.
A half century ago, despite daunting odds and great risk, Pfizer pioneered the mass production of penicillin, thus ushering in the modern pharmaceutical era. Now, more than 12,500 Pfizer scientists at our research facilities around the world continue the quest for new medicines with the same pioneering spirit
.
Today, Pfizer is poised at the cutting edge of science and biotechnology, a position that is strengthened by partnerships and links with more than 250 associates in academia and from within the industry. These partnerships provide Pfizer with access to novel R&D tools and to key data on emerging trends.
|
Clinical
Studies
